SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-24-005460
Filing Date
2024-03-28
Accepted
2024-03-28 16:00:39
Documents
2
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 o319242sc13g.htm SC 13G 85991
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7774
  Complete submission text file 0001214659-24-005460.txt   95568
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-89495 | Film No.: 24798661
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)